Skip to main content

Grow Biotech


We unlock the medical potential of cannabis for those who need it!

Our mission

Our market access team launches medical cannabis producers’ businesses into new markets to create long term value for them.

Our R&D team creates new technologies for medical cannabis producers to create better, cost effective medicines.

Our approach

Our innovations drive the cannabis industry towards the level of sophistication required to meet the needs of patients globally. By building knowledge and the application of science, global markets and technology, we will create significant long-term value.

Our services

We are proud to develop pragmatic solutions to the greatest technological challenges across the value chain, building a professional industry that can offer patients uninterrupted access to the medicines they need.

Research & Development

In state-of-the-art labs in both the UK and in Canada, our interdisciplinary scientific team focuses on developing tools and processes that are underdeveloped as a consequence of years of prohibition of cannabis. We focus on creating innovative technology for transforming the cannabis industry itself, rather than products for cannabis consumers.

Market Access

Having developed significant expertise in the cross-border supply of cannabis, we navigate challenging regulatory frameworks to ensure frictionless movement across the world in support of patients and scientific research.


We use technology to enhance the solutions we create for complex problems. We believe that it is essential to make the process of acquiring medication reliable, fast and easy and this can be achieved via the appropriate use of technology.

Recent Work

We are addressing cannabis industry inefficiencies globally with projects or offices in the UK the USA, and Canada.

“Grow Biotech are industry leaders. Their passion for innovation where it is most needed gives us faith in the future of this vital and disruptive industry.”

Industry Expert, UK

Our leadership team

Our proven team of leaders have broad experience from across science, finance, technology, investing and trade.

Ben Langley

Chief Executive Officer

Ex-JP Morgan Investment Banker and one of the first professional cannabis investors in the UK.

Dr. Ian Atkinson

Chief Scientific Officer

World class geneticist and botanist with decades of R&D leadership experience.

Hari Guliani

Chief Operating Officer

Former corporate finance lawyer & strategy & operations consultant with experience across a wide range of sectors.


In 2019 we are looking to enhance our existing intellectual property portfolio, developing products and processes with the potential to transform the market. With a diversified commercial model solving high-value problems using our rare combination of scientists, technologists, and commercial problem-solvers, we see significant shareholder value being created.

Join Us!

We are intent on transforming the industry, and our workload is growing fast – we want to hear from motivated candidates with an appetite to learn about the complexities of the industry, ready to help change how the market operates.

View our opportunities

Connect with us

Our expert team has experience in supporting clients from across the medical cannabis industry, providing bespoke solutions at each stage and for each stakeholder, for producers to patients. Reach out to discover how we can help you grow.


Portman House
2 Portman Street,
London, W1H 6DU